Crossmark

Hospital attendance, malaria prevalence and self-medication with an antimalarial drug before and after the start of COVID-19 pandemic in a sentinel site for malaria surveillance in Gabon

Crossref DOI link: https://doi.org/10.1186/s12936-025-05272-2

Published Online: 2025-01-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mawili-Mboumba, Denise Patricia

Batchy Ognagosso, Fanny Bertrande

M’Bondoukwé, Noé Patrick

Ndong Ngomo, Jacques Mari

Moutombi Ditombi, Bridy Chesly

Agbanrin, Ahmed Adissa

Nymane, Tatiana

Pongui Ngondza, Bedrich

Moutongo Mouandza, Reinne

Mihindou, Coella Joyce

Mabika Moussavou, Dimitri Ardin

Mbang Nguema, Ornella Anaïse

Bouyou-Akotet, Marielle Karine
License Information

Text and Data Mining valid from 2025-01-25

Version of Record valid from 2025-01-25
More Information

Article History

Received: 13 July 2024

Accepted: 22 January 2025

First Online: 25 January 2025

Declarations

:

: In Gabon, the Ministry of Health, represented by the Malaria National Control Programme, has committed the Department of Parasitology-Mycology and Tropical Medicine of the Faculty of Medicine of Libreville to monitor malaria prevalence and anti-malarial drug resistance in sentinel sites for malaria surveillance. The approval was obtained by the MNCP for the publication of the data. Adolescents and children’s parents or guardians attending the sentinel site were informed on the purpose of the use of their data, for public health or research purpose. In this context, patients and the guardian or parent of the children included were informed of the activities in this sentinel site and their signed consent was obtained. Children over the age of 12 gave their consent to participate in the study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below